Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
2004 1
2005 2
2006 4
2007 19
2008 12
2009 14
2010 10
2011 10
2012 3
2013 5
2014 8
2015 5
2016 13
2017 10
2018 6
2019 9
2020 21
2021 24
2022 16
2023 25
2024 33

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

218 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome: The STOPDAPT-2 ACS Randomized Clinical Trial.
Watanabe H, Morimoto T, Natsuaki M, Yamamoto K, Obayashi Y, Ogita M, Suwa S, Isawa T, Domei T, Yamaji K, Tatsushima S, Watanabe H, Ohya M, Tokuyama H, Tada T, Sakamoto H, Mori H, Suzuki H, Nishikura T, Wakabayashi K, Hibi K, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Morino Y, Kadota K, Furukawa Y, Nakagawa Y, Kimura T; STOPDAPT-2 ACS Investigators. Watanabe H, et al. JAMA Cardiol. 2022 Apr 1;7(4):407-417. doi: 10.1001/jamacardio.2021.5244. JAMA Cardiol. 2022. PMID: 35234821 Free PMC article. Clinical Trial.
An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial.
Natsuaki M, Watanabe H, Morimoto T, Yamamoto K, Obayashi Y, Nishikawa R, Ando K, Domei T, Suwa S, Ogita M, Isawa T, Takenaka H, Yamamoto T, Ishikawa T, Hisauchi I, Wakabayashi K, Onishi Y, Hibi K, Kawai K, Yoshida R, Suzuki H, Nakazawa G, Kusuyama T, Morishima I, Ono K, Kimura T. Natsuaki M, et al. Among authors: nakazawa g. Circulation. 2024 Feb 20;149(8):585-600. doi: 10.1161/CIRCULATIONAHA.123.066720. Epub 2023 Nov 23. Circulation. 2024. PMID: 37994553 Clinical Trial.
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR.
Van Mieghem NM, Unverdorben M, Hengstenberg C, Möllmann H, Mehran R, López-Otero D, Nombela-Franco L, Moreno R, Nordbeck P, Thiele H, Lang I, Zamorano JL, Shawl F, Yamamoto M, Watanabe Y, Hayashida K, Hambrecht R, Meincke F, Vranckx P, Jin J, Boersma E, Rodés-Cabau J, Ohlmann P, Capranzano P, Kim HS, Pilgrim T, Anderson R, Baber U, Duggal A, Laeis P, Lanz H, Chen C, Valgimigli M, Veltkamp R, Saito S, Dangas GD; ENVISAGE-TAVI AF Investigators. Van Mieghem NM, et al. N Engl J Med. 2021 Dec 2;385(23):2150-2160. doi: 10.1056/NEJMoa2111016. Epub 2021 Aug 28. N Engl J Med. 2021. PMID: 34449183 Clinical Trial.
No Epicardial Fat, No Plaque Rupture.
Torii S, Nakazawa G. Torii S, et al. Among authors: nakazawa g. Circ J. 2020 Apr 24;84(5):702-703. doi: 10.1253/circj.CJ-20-0249. Epub 2020 Apr 11. Circ J. 2020. PMID: 32281580 Free article. No abstract available.
Preprocedural physiological assessment of coronary disease patterns to predict haemodynamic outcomes post-PCI.
Kotoku N, Ninomiya K, Masuda S, O'Leary N, Garg S, Naito M, Miyashita K, Tobe A, Kageyama S, Tsai TY, Revaiah PC, Tu S, Kozuma K, Kawashima H, Ishibashi Y, Nakazawa G, Takahashi K, Okamura T, Miyazaki Y, Tateishi H, Nakamura M, Kogame N, Asano T, Nakatani S, Morino Y, Ishida M, Katagiri Y, Ono M, Hara H, Sotomi Y, Tanabe K, Ozaki Y, Muramatsu T, Dijkstra J, Onuma Y, Serruys PW. Kotoku N, et al. Among authors: nakazawa g. EuroIntervention. 2023 Dec 18;19(11):e891-e902. doi: 10.4244/EIJ-D-23-00516. EuroIntervention. 2023. PMID: 37960875 Free article.
Determination of lipid-rich plaques by artificial intelligence-enabled quantitative computed tomography using near-infrared spectroscopy as reference.
Omori H, Matsuo H, Fujimoto S, Sobue Y, Nozaki Y, Nakazawa G, Takahashi K, Osawa K, Okubo R, Kaneko U, Sato H, Kajiya T, Miyoshi T, Ichikawa K, Abe M, Kitagawa T, Ikenaga H, Saji M, Iguchi N, Ijichi T, Mikamo H, Kurata A, Moroi M, Iijima R, Malkasian S, Crabtree T, Min JK, Earls JP, Nakanishi R. Omori H, et al. Among authors: nakazawa g. Atherosclerosis. 2023 Dec;386:117363. doi: 10.1016/j.atherosclerosis.2023.117363. Epub 2023 Oct 29. Atherosclerosis. 2023. PMID: 37944269 Free article.
An Aspirin-Free Strategy for Immediate Treatment Following Complex Percutaneous Coronary Intervention.
Yamamoto K, Natsuaki M, Watanabe H, Morimoto T, Obayashi Y, Nishikawa R, Ando K, Suwa S, Isawa T, Takenaka H, Ishikawa T, Tamura T, Kawahatsu K, Hayashi F, Akao M, Serikawa T, Mori H, Kawamura T, Hagikura A, Shibata N, Ono K, Kimura T; STOPDAPT-3 Investigators. Yamamoto K, et al. JACC Cardiovasc Interv. 2024 May 13;17(9):1119-1130. doi: 10.1016/j.jcin.2024.03.017. JACC Cardiovasc Interv. 2024. PMID: 38749592
Drug-eluting stent pathology--should we still be cautious?
Nakazawa G, Finn AV, Virmani R. Nakazawa G, et al. Nat Clin Pract Cardiovasc Med. 2008 Jan;5(1):1. doi: 10.1038/ncpcardio1093. Nat Clin Pract Cardiovasc Med. 2008. PMID: 18094669 No abstract available.
Virtual histology: does it add anything?
Nakazawa G, Finn AV, Virmani R. Nakazawa G, et al. Heart. 2007 Aug;93(8):897-8. doi: 10.1136/hrt.2006.109371. Heart. 2007. PMID: 17639103 Free PMC article.
Pathology of atherosclerosis and stenting.
Kolodgie FD, Nakazawa G, Sangiorgi G, Ladich E, Burke AP, Virmani R. Kolodgie FD, et al. Among authors: nakazawa g. Neuroimaging Clin N Am. 2007 Aug;17(3):285-301, vii. doi: 10.1016/j.nic.2007.03.006. Neuroimaging Clin N Am. 2007. PMID: 17826632 Free PMC article. Review.
218 results